51暗网

Apply Giving
Resources for:
Students

Theodore Johnson

Professor

Theodore Johnson

Professor

Academic Appointment(s)

Medical College of Georgia
Department of Pediatrics: Hematology/Oncology

Medical College of Georgia
Department of Georgia Cancer Center

Medical College of Georgia
Department of Neuroscience and Regenerative Medicine

Administration
Department of The Graduate School

  • THJOHNSON@augusta.edu
  • (706) 721-4962
  • (706) 721-3925
  • CN 4142

Education

  • MD, Medicine Medical College of Georgia, 2004

  • Ph.D., Molecular Medicine. 51暗网, 2004

  • BS, Chemistry, General Georgia Institute of Technolog, 1997

Certifications

  • PHY Ga Comp Med Brd, 2010

Awards & Honors

  • Recognition of 鈥渁 critical advance in the field of neuroscience鈥� and invitation to give an encore presentation American Academy of Neurology (AAN) Science Committee, AAN 2023 Annual Meeting, Platform presentation, 2023

  • Exemplary Teaching Award MCG, 2021

  • Exemplary Teaching Award MCG, 2017

  • Outstanding Young Clinical Science Faculty Award Medical College of Georgia, Faculty Senate , 2014

  • Champion Award University System of Georgia, MD/PhD Program, 2012

Courses Taught Most Recent Academic Year

  • PEDS 5000

    Basic Clkshp in PEDS

  • PEDS 5009

    Pediatric Sub-I

  • RPED 5002

    Pediatrics General

Teaching Interests

I teach medical students and resident physicians in the art and science of pediatric hematology and oncology.

Scholarship

Selected Recent Publications

  • Indoximod-based chemo-immunotherapy for pediatric brain tumors: a first-in-children phase 1 trial, 2024
    Journal Article, Academic Journal
  • Inhibition of the BTK-IDO-mTOR axis promotes differentiation of monocyte-lineage dendritic cells and enhances anti-tumor T cell immunity, 2021
    Journal Article, Professional Journal
  • Etoposide selectively ablates activated T cells to control the immunoregulatory disorder hemophagocytic lymphohistiocytosis, 2014
    Journal Article, Academic Journal
  • Host indoleamine 2,3-dioxygenase: Contribution to systemic acquired tumor tolerance, 2012
    Journal Article, Academic Journal
  • Modulation of tumor tolerance in primary central nervous system malignancies, 2012
    Journal Article, Academic Journal

Research Interests

I am a physician-scientist and pediatric oncologist, concentrating on developing multi-modal chemo-immunotherapy for children with brain cancer. In my molecular immunology Ph.D. training, I was part of the research team that first reported the groundbreaking discovery of the immune-suppressive potential of indoleamine 2,3-dioxygenase (IDO) in human cancer, and the team that developed indoximod, a small-molecule inhibitor of the IDO pathway used in this proposal. I am the co-founder and Co-Director of the Pediatric Immunotherapy Program at 51暗网, where I oversee clinical trial operations.